In summary, we have uncovered KDM5C as a novel female-biased tumor suppressor in AML, which sustains leukemic differentiation via removal of H3K4me3 methylation at promoters of bivalently marked immature genes. Here, KDM5C is linked to acute myeloid leukemia.